CGIM
BHVN icon

Cannon Global Investment Management’s Biohaven BHVN Stock Holding History

Cannon Global Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,903
Closed -$2.65M – 26
2022
Q3 		$2.65M Buy
+17,903
New +$130K 4.27% 9

Other funds holding BHVN

Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Cannon Global Investment Management's BHVN Position: Q4 2022 in Review

Cannon Global Investment Management sold out of Biohaven (BHVN) in Q4 2022, closing a stake of 17,903 shares — an estimated $2.65M sold.

Cannon Global Investment Management first reported a position in BHVN in Q3 2022 and held it in 1 quarter. The position peaked at $2.65M in Q3 2022. 176 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Cannon Global Investment Management reported no remaining Biohaven position as of Q4 2022 after selling out during the quarter.
  • Cannon Global Investment Management sold 17,903 Biohaven shares in Q4 2022, an estimated $2.65M.
  • Cannon Global Investment Management first reported a position in Biohaven in Q3 2022 and held it in 1 quarter.
  • Cannon Global Investment Management's Biohaven position peaked at $2.65M in Q3 2022.
  • 176 funds tracked by Wall St. Rank held Biohaven as of Q4 2022.

Based on Cannon Global Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.